Scholarlink

<p>Women of transgender experience (WTE) have been disproportionately burdened by mpox. Using 2024 data from the New York City site of the National HIV Behavioral Surveillance study among WTE and transfeminine people (TFP), we identified factors associated with receiving at least one dose of the mpox vaccine. Of 103 WTE/TFP, most identified as Hispanic/Latina and being born outside of the United States with 40% receiving at least one dose. Participants who self-reported having HIV were more than twice as likely to have received a dose (PR: 2.31; 95% CI: 1.20–4.47). Mpox vaccine outreach efforts may benefit from status-neutral strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Factors Associated with Mpox Vaccination Uptake Among Women of Transgender Experience and Transfeminine People in New York City, 2024

  • 期刊论文

  • 发表日期：

    2026年3月3日

查看全文
  • Alexis V. Rivera,
  • Kristina Rodriguez,
  • Mimi Shelton,
  • Zoe Edelstein

摘要

Women of transgender experience (WTE) have been disproportionately burdened by mpox. Using 2024 data from the New York City site of the National HIV Behavioral Surveillance study among WTE and transfeminine people (TFP), we identified factors associated with receiving at least one dose of the mpox vaccine. Of 103 WTE/TFP, most identified as Hispanic/Latina and being born outside of the United States with 40% receiving at least one dose. Participants who self-reported having HIV were more than twice as likely to have received a dose (PR: 2.31; 95% CI: 1.20–4.47). Mpox vaccine outreach efforts may benefit from status-neutral strategies.